A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of Medicine at Mount Sinai has found that the serum of patients with major ...

Psychedelics are psychoactive substances that trigger unusual mental states, also referred to as "trips," altering the ...

Could a smart watch act as an early‑warning system for depression relapse? New research from McMaster University suggests ...

Doha Design District (DDD) has reinforced its status as the region’s leading creative powerhouse after hosting a landmark week of international art and des ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

Ten people are dead, including the suspected shooter, after a mass shooting at Tumbler Ridge Secondary School in British ...

A new UT Austin clinical trial is testing a fast‑acting treatment for postpartum depression that doesn’t require drugs, ...

For the full year 2025, Neurocrine reported total net product sales of $2.83 billion, a 22% increase from the previous year. INGREZZA sales grew 9% to $2.51 billion, while CRENESSITY, which was ...

As of Wednesday, February 11, Neuronetics, Inc.’s STIM share price has surged by 21.58%, which has investors questioning if this is right time to sell.

All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth ...

The number of British troops in Norway will double as part of efforts to bolster defences in the High North against Vladimir ...

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.